Physician profile
Hannah Archer
NPI 1629737721
$590.75
in general payments reported to CMS, 2019-2025
15 companies · $484 in 2025
The $484 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $15.04 · 2024: $91.66 · 2025: $484.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $591.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $590.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $173.97 | 2025 | Clottriever Bold Catheter |
| Sumitomo Pharma America, INC. | $67.78 | 2025 | Gemtesa, Myfembree |
| Exeltis, USA INC. | $62.22 | 2024-2025 | Slynd |
| Hologic Sales and Service, LLC | $43.81 | 2025 | Aptima, Novasure |
| Mayne Pharma Commercial LLC | $42.94 | 2025 | |
| Astellas Pharma US INC | $32.23 | 2025 | Veozah, Xtandi |
| Sage Therapeutics, LLC | $26.58 | 2024 | |
| Urogen Pharma, INC. | $23.65 | 2025 | |
| Baxter Healthcare | $22.00 | 2025 | Tisseel |
| Boston Scientific Corporation | $18.93 | 2025 | Axonics |
| Organon LLC | $17.01 | 2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $15.32 | 2024 | |
| Millicent US INC | $15.29 | 2025 | Intrarosa |
| Servier Pharmaceuticals LLC | $15.04 | 2023 | |
| Gynesonics, INC. | $13.98 | 2024 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hannah Archer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.